# The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)

> **NCT01116115** · NA · COMPLETED · sponsor: **Enzymotec** · enrollment: 30 (actual)

## Conditions studied

- Health Behavior
- Disorder of Growth and Development

## Interventions

- **OTHER:** InFat™ based infant formula
- **OTHER:** Standard vegetable oil based infant formula

## Key facts

- **NCT ID:** NCT01116115
- **Lead sponsor:** Enzymotec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116115, "The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01116115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*